Catalyst Pharmaceuticals, Inc.: documents
16 reports and filings since Aug 7, 2024, each linked to the copy the company filed with the regulator.
Annual reports#
3 on file.
- Apr 30, 202610-K/AAnnual report, amended, period to 31 December 2025all files
- Feb 25, 202610-KAnnual report, period to 31 December 2025all files
- Feb 26, 202510-KAnnual report, period to 31 December 2024all files
Quarterly reports#
6 on file.
- May 11, 202610-QQuarterly report, period to 31 March 2026all files
- Nov 5, 202510-QQuarterly report, period to 30 September 2025all files
- Aug 6, 202510-QQuarterly report, period to 30 June 2025all files
- May 7, 202510-QQuarterly report, period to 31 March 2025all files
- Nov 6, 202410-QQuarterly report, period to 30 September 2024all files
- Aug 7, 202410-QQuarterly report, period to 30 June 2024all files
Proxy statements#
1 on file.
- Apr 11, 2025DEF 14AProxy statement, period to 20 May 2025all files
Other current reports#
6 on file.
- Jul 16, 20268-KTaken over and delisted; Change in control; Acquisition or sale completed; Directors and officers; Shareholder rights changed; Bylaws or fiscal year changedall files
- Jul 8, 20268-KDirectors and officers; Shareholder voteall files
- May 7, 20268-KMaterial agreement; Bylaws or fiscal year changedall files
- Aug 4, 20258-KDirectors and officersall files
- May 23, 20258-KDirectors and officers; Shareholder voteall files
- Jan 24, 20258-KDirectors and officersall files
Source: SEC EDGAR filings and ESEF annual reports (filings.xbrl.org). Results announcements are 8-K filings with item 2.02: the press release is one of the filing's exhibits, under "all files". Every filing of the company is on EDGAR. The figures read from these reports